Future studies involving transcriptomic profiling, m5C mapping and pathway perturbation are needed to uncover the specific biological targets and regulatory networks through which NSUN6 mediates its tumor‐suppressive effects in glioma. This evidence concerns the gene NSUN6 and central nervous system cancer.